Company page

Nextcure, Inc.

Nextcure, Inc. is a public company traded under the ticker NXTC on the American market. With a market capitalization of approximately $7.3 million, Nextcure focuses on advancing innovative therapies in the field of immuno-oncology. The company is dedicated to developing treatments that target various types of cancer.